SA
Sign upLog In

Regeneron Pharmaceuticals (REGN)

Cost of Revenue

$2.35B

TTM · Period ending: · USD

REGN logo

REGN Cost of Revenue

Latest reported$2.35B
REGN TTM Cost of Revenue ($0.00 → $2.35B)
High-resolution chart · PNG

REGN cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regeneron Pharmaceuticals Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
2,352,100,000
2,305,800,000
2,100,700,000
2,081,500,000
2,051,000,000
2,001,000,000
1,970,500,000
2,034,200,000
2,084,900,000
2,112,700,000
2,235,900,000
2,113,800,000
1,982,400,000
1,845,900,000
1,768,100,000
2,318,199,999
2,434,199,999
2,827,499,999
2,723,699,999
2,081,400,000
1,888,300,000
1,457,800,000
1,355,800,000
1,217,000,000
1,162,100,000
1,025,700,000
975,400,000
859,359,000
726,769,000
654,172,000
582,328,000
562,616,000
558,757,000
571,501,000
542,528,000
505,862,000
435,978,000
366,964,000
356,433,000
363,683,000
400,699,000
420,506,000
392,709,000
341,352,000
287,862,000
245,401,000
205,018,000
193,658,000
176,638,000
169,872,000
155,355,000
137,410,000
118,982,000
101,212,000
84,455,000
57,275,000
37,580,000
16,132,000
4,216,000
1,826,000
1,748,000
1,758,000
2,093,000
1,881,000
1,981,000
2,011,000
1,686,000
1,930,000
1,750,000
1,321,900
929,900
298,900
6,900
0
0
430,000
3,484,000
6,294,000
8,146,000
9,861,000
10,053,000
8,918,000
9,557,000
10,886,000
16,626,000
15,480,000
15,214,000
12,647,000
8,505,000
8,235,000
6,676,000
7,495,000
4,288,000
5,890,000
6,483,000
5,919,000
5,556,000
5,580,000
6,509,000
14,085,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.